Physician profile
Michael T Mccormack
NPI 1114934676
$2,676.89
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,219 · 2020: $546 · 2021: $470 · 2022: $414 · 2023: $27.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $414.99 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $326.52 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $321.06 | 2019-2022 | |
| Insmed, INC. | $283.43 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $262.56 | 2019-2021 | |
| United Therapeutics Corporation | $202.15 | 2019-2022 | |
| Grifols USA, LLC | $185.96 | 2019-2021 | |
| Genentech USA, INC. | $136.90 | 2019-2021 | |
| Abbvie INC. | $130.42 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $88.80 | 2019-2020 | |
| Cook Medical LLC | $82.27 | 2019 | |
| Inogen, INC. | $56.32 | 2022 | |
| Sunovion Pharmaceuticals INC. | $30.70 | 2019-2020 | |
| Electromed, INC. | $25.43 | 2019 | |
| Baxter Healthcare | $21.08 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vapotherm INC | $19.90 | 2022 | |
| Olympus America INC. | $19.03 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.22 | 2021 | |
| Gilead Sciences, INC. | $14.75 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.54 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.40 | 2019 | |
| Pfizer INC. | $11.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mccormack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.